As of 2024-12-14, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (36.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -196.3%.
The range of the Relative Valuation is (34.04) - (31.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.7x - 31.0x | 25.8x |
| Forward P/E multiples | 18.7x - 19.2x | 19.0x |
| Fair Price | (34.04) - (31.57) | (36.80) |
| Upside | -189.1% - -182.6% | -196.3% |
| Date | P/E |